Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
H05BX01	CINACALCET ARROW	BioTech	Cinacalcet - 60mg	60mg	Tablet, coated, scored	16,494,074 L.L
J01BA01	CHLORAMPHENICOL PALMITATE	G	Chloramphenicol (palmitate) - 125mg/5ml	125mg/5ml	Suspension	159,981 L.L
J01BA01	CHLORAMPHENICOL	G	Chloramphenicol - 250mg	250mg	Capsule	166,381 L.L
J01CR02	CURAM	G	Amoxicillin (trihydrate) - 500mg, Clavulanic Acid (potassium) - 125mg	625mg	Tablet, film coated	402,189 L.L
J01CR02	CURAM	G	Amoxicillin (trihydrate) - 875mg, Clavulanic Acid (potassium) - 125mg	1g	Tablet, film coated	541,236 L.L
J01DB04	CEFAZOL IM/IV	G	Cefazolin (sodium) - 1g	1g	Injectable powder	5,375,370 L.L
J01DB04	CEFAZOLIN PANPHARMA	G	Cefazolin (sodium) - 1g	1g	Injectable powder for solution	5,521,849 L.L
J01DB04	CEFAZOLINA	G	Cefazolin (sodium) - 1g	1g	Injectable powder for solution	18,574,396 L.L
J01DB05	CEFADRIL	G	Cefadroxil (monohydrate) - 250mg/5ml	250mg/5ml	Powder for suspension	268,769 L.L
J01DB05	CEFADRIL	G	Cefadroxil (monohydrate) - 500mg	500mg	Capsule	450,187 L.L
J01DC02	CEFUMAX	G	Cefuroxime (sodium) - 750mg	750mg	Injectable dry powder	159,917 L.L
J01DC02	CEFUROXIME – PANPHARMAPOUDRE POUR SOLUTION INJ. IM/IV	G	Cefuroxime (sodium) - 750mg	750mg	Injectable dry powder	3,922,676 L.L
J01DC02	CEFUROXIME – PANPHARMAPOUDRE POUR SOLUTION INJ. IM/IV	G	Cefuroxime (sodium) - 750mg	750mg	Injectable powder for solution	1,651,582 L.L
J01DC02	CEFUZIME	G	Cefuroxime (sodium) - 750mg	750mg	Injectable dry powder	147,823 L.L
J01DC02	CEFORA	G	Cefuroxime (axetil) - 500mg	500mg	Tablet	703,918 L.L
J01DC02	CEFUREX	G	Cefuroxime - 500mg	500mg	Tablet	490,503 L.L
J01DC02	CEFUZIME	G	Cefuroxime (axetil) - 500mg	500mg	Tablet, film coated	490,503 L.L
J01DC04	CECLOR	B	Cefaclor (monohydrate) - 250mg/5ml	250mg/5ml	Granules for suspension	851,100 L.L
J01DC04	CLORACEF FORTE	G	Cefaclor (monohydrate) - 250mg/5ml	250mg/5ml	Powder for suspension	632,950 L.L
J01DC04	CECLOR MR	B	Cefaclor (monohydrate) - 500mg	500mg	Tablet, film coated, modified release	1,226,096 L.L
J01DC04	CECLOR MR	B	Cefaclor (monohydrate) - 750mg	750mg	Tablet, film coated, modified release	1,555,018 L.L
J01DC04	CECLOR	B	Cefaclor (monohydrate) - 125mg/5ml	125mg/5ml	Granules for suspension	487,623 L.L
J01DC10	CEFPROZ	G	Cefprozil - 500mg	500mg	Tablet, film coated	1,737,588 L.L
J01DC10	CEFPROZ 250	G	Cefprozil - 250mg/5ml	250mg/5ml	Powder for suspension	712,237 L.L
J01DC10	CEFPROZ 250	G	Cefprozil - 250mg/5ml	250mg/5ml	Powder for suspension	1,343,843 L.L
J01DD01	CEFOTAX	G	Cefotaxime (sodium) - 1g	1g	Injectable lyophilised powder for solution+diluent	217,702 L.L
J01DD01	CEFOTAXIME PANPHARMA	G	Cefotaxime (sodium) - 1g	1g	Injectable lyophilised powder for solution	6,127,922 L.L
J01DD01	CLAFOCARE	G	Cefotaxime (sodium) - 1g	1g	Injectable powder for solution	8,031,731 L.L
J01DD02	CEFTAZIDIME PANPHARMA	G	Ceftazidime (pentahydrate) - 1g	1g	Injectable powder for solution	3,300,477 L.L
J01DD04	CEFAXONE	G	Ceftriaxone - 1g	1g	Injectable powder	403,153 L.L

...